Chondroitin Sulphate Proteoglycan 4 (CSPG4), an Attractive Target of Antibody-based Immunotherapy in Various Types of Solid Tumors
Speaker
Soldano Ferrone(Dept of Surgery, Massachusetts General Hospital, Harvard Medical School, United States Of America (usa))
Date and Venue
IMCB Seminar Room 3-46, Level 3, Proteos, Biopolis-
26 November 2014
11:00 am - 12:00 pm
